Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Ocular Immune Privilege and Transplantation

Open access
Taylor, Andrew W. · 2016 · Frontiers in Immunology

Abstract

Allografts are afforded a level of protection from rejection within immune-privileged tissues. Immune-privileged tissues involve mechanisms that suppress inflammation and promote immune tolerance. There are anatomical features, soluble factors, membrane-associated proteins, and alternative antigen-presenting cells (APC) that contribute to allograft survival in the immune-privileged tissue. This review presents the current understanding of how the mechanism of ocular immune privilege promotes tolerogenic activity by APC, and T cells in response to the placement of foreign antigen within the ocular microenvironment. Discussed will be the unique anatomical, cellular, and molecular mechanisms that lessen the chance for graft destroying immune responses within the eye. As more is understood about the molecular mechanisms of ocular immune privilege greater is the potential for using these molecular mechanisms in therapies to prevent allograft rejection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2016.00037

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 91

  1. Medawar, 1948, Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain to subcutaneous tissue, and to the anterior chamber of the eye, Br J Exp Pathol, 29, 58
  2. Barker, 1968, The role of afferent lymphatics in the rejection of skin homografts, J Exp Med, 128, 197, 10.1084/jem.128.1.197 · DOI · Paper page
  3. McMenamin, 1992, Class II major histocompatibility complex (Ia) antigen-bearing dendritic cells within the iris and ciliary body of the rat eye: distribution, phenotype, and relation to retinal microglia, Immunology, 77, 385
  4. Paques, 2010, In vivo observation of the locomotion of microglial cells in the retina, Glia, 58, 1663, 10.1002/glia.21037 · DOI
  5. Hamrah, 2007, Corneal antigen-presenting cells, Chem Immunol Allergy, 92, 58, 10.1159/000099254 · DOI · Paper page
  6. Knickelbein, 2009, Stratification of antigen-presenting cells within the normal cornea, Ophthalmol Eye Dis, 1, 45, 10.4137/OED.S2813 · DOI
  7. Hamrah, 2002, Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells, Invest Ophthalmol Vis Sci, 43, 639
  8. Albini, 2005, Microglial stability and repopulation in the retina, Br J Ophthalmol, 89, 901, 10.1136/bjo.2004.060293 · DOI
  9. Dullforce, 2004, APCs in the anterior uveal tract do not migrate to draining lymph nodes, J Immunol, 172, 6701, 10.4049/jimmunol.172.11.6701 · DOI
  10. Chen, 2002, Distribution, markers, and functions of retinal microglia, Ocul Immunol Inflamm, 10, 27, 10.1076/ocii.10.1.27.10328 · DOI · Paper page
  11. Kaneko, 2008, Characteristics of bone marrow-derived microglia in the normal and injured retina, Invest Ophthalmol Vis Sci, 49, 4162, 10.1167/iovs.08-1738 · DOI
  12. Ajami, 2007, Local self-renewal can sustain CNS microglia maintenance and function throughout adult life, Nat Neurosci, 10, 1538, 10.1038/nn2014 · DOI · Paper page
  13. Eter, 2008, In vivo visualization of dendritic cells, macrophages, and microglial cells responding to laser-induced damage in the fundus of the eye, Invest Ophthalmol Vis Sci, 49, 3649, 10.1167/iovs.07-1322 · DOI
  14. McMenamin, 1995, Endotoxin-induced uveitis. Kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body, Invest Ophthalmol Vis Sci, 36, 1949
  15. Campbell, 2012, The blood-retina barrier: tight junctions and barrier modulation, Adv Exp Med Biol, 763, 70, 10.1007/978-1-4614-4711-5_3 · DOI · Paper page
  16. Taylor, 1992, Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor, Curr Eye Res, 11, 1199, 10.3109/02713689208999545 · DOI · Paper page
  17. Taylor, 1994, Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor, J Immunol, 153, 1080, 10.4049/jimmunol.153.3.1080 · DOI · Paper page
  18. Goslings, 1998, Small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation, Invest Ophthalmol Vis Sci, 39, 989
  19. Taylor, 1998, Suppression of nitric oxide generated by inflammatory microphages by calcitonin gene-related peptide in aqueous humor, Invest Ophthalmol Vis Sci, 39, 1372
  20. Taylor, 2003, Somatostatin is an imunosuppressive factor in aqueous humor, Invest Ophthalmol Vis Sci, 44, 2644, 10.1167/iovs.02-1216 · DOI
  21. Zamiri, 2006, Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation, Invest Ophthalmol Vis Sci, 47, 3912, 10.1167/iovs.05-1267 · DOI
  22. Zamiri, 2007, Thrombospondin plays a vital role in the immune privilege of the eye, Ocul Immunol Inflamm, 15, 279, 10.1080/09273940701382432 · DOI
  23. Kawanaka, 2011, Localized retinal neuropeptide regulation of macrophage and microglial cell functionality, J Neuroimmunol, 232, 17, 10.1016/j.jneuroim.2010.09.025 · DOI
  24. Apte, 1998, Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege, J Immunol, 160, 5693, 10.4049/jimmunol.160.12.5693 · DOI · Paper page
  25. D’Orazio, 1999, Effect of aqueous humor on apoptosis of inflammatory cell types, Invest Ophthalmol Vis Sci, 40, 1418
  26. Wenkel, 2000, Evidence that retinal pigment epithelium functions as an immune-privileged tissue, Invest Ophthalmol Vis Sci, 41, 3467
  27. Ishida, 2003, Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms, Ocul Immunol Inflamm, 11, 91, 10.1076/ocii.11.2.91.15914 · DOI
  28. Sugita, 2006, B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells, Invest Ophthalmol Vis Sci, 47, 5376, 10.1167/iovs.05-1354 · DOI
  29. Kawazoe, 2012, Retinoic acid from retinal pigment epithelium induces T regulatory cells, Exp Eye Res, 94, 32, 10.1016/j.exer.2011.11.002 · DOI
  30. Sugita, 2006, Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta, Exp Eye Res, 83, 1459, 10.1016/j.exer.2006.08.005 · DOI
  31. Sugita, 2009, Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions, J Immunol, 183, 5013, 10.4049/jimmunol.0901623 · DOI
  32. Sugita, 2009, T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions, Invest Ophthalmol Vis Sci, 50, 2862, 10.1167/iovs.08-2846 · DOI
  33. Sugita, 2009, Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism, Invest Ophthalmol Vis Sci, 50, 263, 10.1167/iovs.08-2536 · DOI
  34. Bora, 1993, Differential expression of the complement regulatory proteins in the human eye, Invest Ophthalmol Vis Sci, 34, 3579
  35. Niederkorn, 2010, History and physiology of immune privilege, Ocul Immunol Inflamm, 18, 19, 10.3109/09273940903564766 · DOI
  36. Streilein, 1980, Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens, J Exp Med, 152, 1121, 10.1084/jem.152.4.1121 · DOI
  37. Jiang, 1990, Immunologic privilege evoked by histoincompatible intracameral retinal transplants, Reg Immunol, 3, 121
  38. Niederkorn, 2003, The immune privilege of corneal grafts, J Leukoc Biol, 74, 167, 10.1189/jlb.1102543 · DOI
  39. Liu, 2002, Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts, J Exp Med, 195, 259, 10.1084/jem.20010838 · DOI · Paper page
  40. Sano, 1997, Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in “high-risk” eyes, Curr Eye Res, 16, 1171, 10.1076/ceyr.16.11.1171.5109 · DOI
  41. Ma, 1998, Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts, Invest Ophthalmol Vis Sci, 39, 2384
  42. Streilein, 2002, Immunobiology and privilege of neuronal retina and pigment epithelium transplants, Vision Res, 42, 487, 10.1016/S0042-6989(01)00185-7 · DOI · Paper page
  43. Kaplan, 1975, Transplantation immunology of the anterior chamber of the eye. II. Immune response to allogeneic cells, J Immunol, 115, 805, 10.4049/jimmunol.115.3.805 · DOI
  44. Kaplan, 1977, Immune response to immunization via the anterior chamber of the eye. I. F. Lymphocyte-induced immune deviation, J Immunol, 118, 809, 10.4049/jimmunol.118.3.809 · DOI
  45. Wenkel, 1999, Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space, Invest Ophthalmol Vis Sci, 40, 3202
  46. Sonoda, 2005, The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation, Immunology, 116, 390, 10.1111/j.1365-2567.2005.02239.x · DOI · Paper page
  47. Lin, 2005, The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance, J Exp Med, 201, 1615, 10.1084/jem.20042307 · DOI · Paper page
  48. Streilein, 1981, Induction of anterior chamber-associated immune deviation requires an intact, functional spleen, J Exp Med, 153, 1058, 10.1084/jem.153.5.1058 · DOI · Paper page
  49. Hsu, 2014, Ex-vivo tolerogenic F4/80(+) antigen-presenting cells (APC) induce efferent CD8(+) regulatory T cell-dependent suppression of experimental autoimmune uveitis, Clin Exp Immunol, 176, 37, 10.1111/cei.12243 · DOI
  50. Wilbanks, 1992, Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta, Eur J Immunol, 22, 1031, 10.1002/eji.1830220423 · DOI · Paper page
  51. Hara, 1993, Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type, J Immunol, 151, 5162, 10.4049/jimmunol.151.10.5162 · DOI
  52. Wilbanks, 1992, Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta, Eur J Immunol, 22, 165, 10.1002/eji.1830220125 · DOI · Paper page
  53. Faunce, 2002, NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance, J Immunol, 169, 31, 10.4049/jimmunol.169.1.31 · DOI
  54. D’Orazio, 1998, Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID), Immunology, 95, 47, 10.1046/j.1365-2567.1998.00581.x · DOI
  55. Sonoda, 2002, Ocular immune privilege and CD1d-reactive natural killer T cells, Cornea, 21, S33, 10.1097/00003226-200203001-00008 · DOI
  56. Wilbanks, 1990, Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations, Immunology, 71, 383
  57. Jiang, 2009, Splenic CD8+ T cells secrete TGF-beta1 to exert suppression in mice with anterior chamber-associated immune deviation, Graefes Arch Clin Exp Ophthalmol, 247, 87, 10.1007/s00417-008-0947-8 · DOI
  58. Paunicka, 2012, Role of IFN-gamma in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells, J Leukoc Biol, 91, 475, 10.1189/jlb.0311173 · DOI
  59. Sonoda, 2002, CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance, Eur J Immunol, 32, 848, 10.1002/1521-4141(200203)32:3848::AID-IMMU8483.0.CO;2-I · doi:10.1002/1521-4141(200203)32:3848::aid-immu8483.0.co;2-i
  60. Sonoda, 2002, Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells, J Immunol, 168, 2028, 10.4049/jimmunol.168.4.2028 · DOI
  61. Masli, 2002, Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties, J Immunol, 168, 2264, 10.4049/jimmunol.168.5.2264 · DOI
  62. Streilein, 1990, Aqueous humor factors and their effect on the immune response in the anterior chamber, Curr Eye Res, 9, 175, 10.3109/02713689008999439 · doi:10.3109/02713689008999439
  63. Kim, 1988, Intraocular trafficking of lymphocytes in locally induced experimental autoimmune uveoretinitis (EAU), Cell Immunol, 112, 430, 10.1016/0008-8749(88)90312-7 · doi:10.1016/0008-8749(88)90312-7
  64. Chan, 1988, Dynamics of experimental autoimmune uveoretinitis induced by adoptive transfer of S-antigen-specific T cell line, Invest Ophthalmol Vis Sci, 29, 411
  65. Cousins, 1991, Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor, Invest Ophthalmol Vis Sci, 32, 2201
  66. Connor, 1989, Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye, J Clin Invest, 83, 1661, 10.1172/JCI114065 · DOI · Paper page
  67. Jampel, 1990, Transforming growth factor-beta in human aqueous humor, Curr Eye Res, 9, 963, 10.3109/02713689009069932 · DOI · Paper page
  68. Knisely, 1991, Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells, Curr Eye Res, 10, 761, 10.3109/02713689109013870 · DOI
  69. Kaiser, 1989, Inhibition of lymphocyte proliferation by aqueous humor, Reg Immunol, 2, 42
  70. Taylor, 2009, Review of the activation of TGF-beta in immunity, J Leukoc Biol, 85, 29, 10.1189/jlb.0708415 · DOI · Paper page
  71. Taylor, 2007, Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. 1997, Ocul Immunol Inflamm, 15, 215, 10.1080/09273940701382234 · DOI
  72. Lau, 2009, The immune privileged retina mediates an alternative activation of J774A.1 cells, Ocul Immunol Inflamm, 17, 380, 10.3109/09273940903118642 · DOI
  73. Lee, 2013, Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice, J Immunol, 191, 4103, 10.4049/jimmunol.1300182 · DOI
  74. Stuart, 1997, CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival, J Clin Invest, 99, 396, 10.1172/JCI119173 · DOI · Paper page
  75. Griffith, 1995, Fas ligand-induced apoptosis as a mechanism of immune privilege, Science, 270, 1189, 10.1126/science.270.5239.1189 · DOI · Paper page
  76. Weiss, 2011, Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells, J Immunol, 187, 1684, 10.4049/jimmunol.1002321 · DOI
  77. Francisco, 2010, The PD-1 pathway in tolerance and autoimmunity, Immunol Rev, 236, 219, 10.1111/j.1600-065X.2010.00923.x · DOI · Paper page
  78. Copland, 2007, Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis, Am J Pathol, 171, 580, 10.2353/ajpath.2007.070272 · DOI
  79. Marvel, 2015, Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected, J Clin Invest, 125, 3356, 10.1172/JCI80005 · DOI · Paper page
  80. Crook, 2015, Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease, J Leukoc Biol, 97, 573, 10.1189/jlb.4A0314-139R · DOI
  81. Li, 2015, Myeloid-derived suppressor cells suppress CD4(+) and CD8(+) T cell responses in autoimmune hepatitis, Mol Med Rep, 12, 3667, 10.3892/mmr.2015.3791 · DOI
  82. Jiang, 1991, Immune responses elicited by transplantation and tissue-restricted antigens expressed on retinal tissues implanted subconjunctivally, Transplantation, 52, 513, 10.1097/00007890-199109000-00025 · DOI
  83. Jiang, 2010, Laser injury promotes migration and integration of retinal progenitor cells into host retina, Mol Vis, 16, 983
  84. Ross, 1991, The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts, Transplantation, 52, 857, 10.1097/00007890-199111000-00020 · doi:10.1097/00007890-199111000-00020
  85. Wenkel, 1998, Analysis of immune deviation elicited by antigens injected into the subretinal space, Invest Ophthalmol Vis Sci, 39, 1823
  86. Qiao, 2009, Retinal laser burn disrupts immune privilege in the eye, Am J Pathol, 174, 414, 10.2353/ajpath.2009.080766 · DOI
  87. Ng, 2007, Creating an immune-privileged site using retinal progenitor cells and biodegradable polymers, Stem Cells, 25, 1552, 10.1634/stemcells.2006-0780 · doi:10.1634/stemcells.2006-0780
  88. Taylor, 2001, In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH), Immunol Cell Biol, 79, 358, 10.1046/j.1440-1711.2001.01022.x · DOI
  89. Ng, 2007, In vitro generated autoimmune regulatory T cells enhance intravitreous allogeneic retinal graft survival, Invest Ophthalmol Vis Sci, 48, 5112, 10.1167/iovs.07-0175 · DOI
  90. Hamrah, 2009, Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection, Transplantation, 88, 180, 10.1097/TP.0b013e3181ac11ea · doi:10.1097/tp.0b013e3181ac11ea
  91. Taylor, 2010, Applications of the role of alpha-MSH in ocular immune privilege, Adv Exp Med Biol, 681, 143, 10.1007/978-1-4419-6354-3_12 · DOI

Cited by

See all 171

Metadata

Authors
Taylor, A. W.
Venue
Frontiers in Immunology
Published
2016-02-08
Volume
7
Pages
37-37
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2292805097
Cited by
171
References
10
FWCI
8.41
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ocular Immune Privilege and Transplantation. https://app.cochat.ai/papers/10.3389/fimmu.2016.00037
The paper
Taylor, A. W. (2016). Ocular Immune Privilege and Transplantation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2016.00037

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.